We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences plc | AQSE:PRM.GB | Aquis Stock Exchange | Ordinary Share | GB0003104196 | Ordinary Shares 1p |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.00 | 2.50 | 5.00 | 4.00 | 3.126 | 4.00 | 200,000 | 16:29:52 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPRM
RNS Number : 0878T
Proteome Sciences PLC
30 December 2016
TR-1:NOTIFICATION OFMAJOR INTERESTIN SHARESi -------------------------------------------- 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are PROTEOME SCIENCES PLC attached: ii ----------------------------------------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------- An acquisition or disposal YES of voting rights ---------------------------------------------------------- ----- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ----------------------------------------------------------------- An event changing the breakdown of voting rights ----------------------------------------------------------------- Other (please specify): ---------------------------------------------------------- ----- 3. Full name of person(s) subject to the VULPES LIFE SCIENCES FUND notification obligation: iii VULPES TESTUDO FUND ----------------------------------------------------------------- 4. Full name of shareholder(s) (if different from 3.):iv ---------------------------------------------------------- ----- 5. Date of the transaction and date on which the threshold is crossed or 28 DECEMBER 2016 reached: v ----------------------------------------------------------------- 6. Date on which issuer notified: 29 DECEMBER 2016 ----------------------------------------------------------------- 7. Threshold(s) that is/are crossed or reached: vi, vii 18% ----------------------------------------------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares viii, ix ----------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ---------------------------- ------------------------------------------------------------- Number Number Number Number of voting % of voting of Shares of Voting of shares rights rights Rights x -------------- ------------- ------------- ------------- ------------------------ -------------------- Direct Direct Indirect Direct Indirect xi xii -------------- ------------- ------------- ------------- ------------- --------- --------- --------- GB0003104196 52,973,125 52,973,125 53,238,125 53,238,125 18.09% -------------- ------------- ------------- ------------- ------------- --------- --------- --------- B: Qualifying Financial Instruments --------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Conversion Number of voting % of voting instrument date xiii Period xiv rights that may rights be acquired if the instrument is exercised/ converted. ------------------ ----------- --------------------- ----------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi ---------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date xvii Conversion rights rights xix, period instrument refers xx xviii to ------------------ --------- ----------- ------------ ------------------- --------------- Nomin Delta al ------------------ --------- ----------- ------------ ------------------- ------- ------ Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 53,238,125 18.09% ------------------------ ---------------------------- Proxy Voting: -------------------------------------- 10. Name of the proxy holder: ------------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------ 13. Additional information: executive.pa@proteomics.com ------------------------------ ------------------------------ 14. Contact name: Victoria Birse ------------------------------ ------------------------------ 15. Contact telephone number: ------------------------------ ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLWGGGPPUPQGGU
(END) Dow Jones Newswires
December 30, 2016 06:42 ET (11:42 GMT)
1 Year Proteome Sciences Chart |
1 Month Proteome Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions